Literature DB >> 19351741

The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage.

Friedhelm Beyersdorf1.   

Abstract

Ischaemia and reperfusion occur during almost every cardiac operation, and one of the key elements to achieve a successful operation is to counteract the detrimental effects of induced ischaemia and reperfusion during the operation. The cardiac surgeon is in a unique position to protect the heart before ischaemia is induced and to avoid further damage during the reperfusion period. The surgeon can alter the composition of the reperfusate and the conditions of reperfusion so that the ischaemia/reperfusion injury is minimal, even after very complex procedures that require long aortic cross-clamp periods. This in turn allows him to perform a near-perfect surgical repair of the underlying disease without the pressure of time. The vast knowledge gained in this field over the years has led to application in other organs, such as the limbs (acute limb ischaemia), lungs (lung transplantation), kidney and liver (kidney and liver transplantation), and more recently even for the brain [acute cerebral artery occlusion (stroke)] and the whole body (cardiopulmonary resuscitation). Further improvements in reperfusion strategies will allow salvage of tissue and even whole body after ischaemic periods thought previously to be irreversibly damaged.

Entities:  

Mesh:

Year:  2009        PMID: 19351741     DOI: 10.1093/cvr/cvp110

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  17 in total

1.  Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts.

Authors:  Daniel J Herr; Sverre E Aune; Donald R Menick
Journal:  J Vis Exp       Date:  2015-07-27       Impact factor: 1.355

Review 2.  Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms.

Authors:  Demetria M Fischesser; Bin Bo; Rachel P Benton; Haili Su; Newsha Jahanpanah; Kevin J Haworth
Journal:  J Cardiovasc Pharmacol Ther       Date:  2021-09-17       Impact factor: 2.457

3.  Protective effects of trehalose preconditioning on cardiac and coronary endothelial function through eNOS signaling pathway in a rat model of ischemia-reperfusion injury.

Authors:  Kenichiro Suno; Yasushige Shingu; Satoru Wakasa
Journal:  Mol Cell Biochem       Date:  2022-05-17       Impact factor: 3.842

4.  Gradual Versus Abrupt Reperfusion During Primary Percutaneous Coronary Interventions in ST-Segment-Elevation Myocardial Infarction (GUARD).

Authors:  Murat Sezer; Javier Escaned; Christopher J Broyd; Berrin Umman; Zehra Bugra; Ilke Ozcan; Mehmet Rasih Sonsoz; Alp Ozcan; Adem Atici; Emre Aslanger; Z Irem Sezer; Justin E Davies; Niels van Royen; Sabahattin Umman
Journal:  J Am Heart Assoc       Date:  2022-05-16       Impact factor: 6.106

5.  Effect of anesthesia and cerebral blood flow on neuronal injury in a rat middle cerebral artery occlusion (MCAO) model.

Authors:  C Bleilevens; A B Roehl; A Goetzenich; N Zoremba; M Kipp; J Dang; R Tolba; R Rossaint; M Hein
Journal:  Exp Brain Res       Date:  2012-10-13       Impact factor: 1.972

6.  In vivo quantification of VCAM-1 expression in renal ischemia reperfusion injury using non-invasive magnetic resonance molecular imaging.

Authors:  Asim M Akhtar; Jurgen E Schneider; Stephanie J Chapman; Andrew Jefferson; Janet E Digby; Kulveer Mankia; Ye Chen; Martina A McAteer; Kathryn J Wood; Robin P Choudhury
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

Review 7.  Mitochondrial Dysfunction in Cardiac Surgery.

Authors:  Anne D Cherry
Journal:  Anesthesiol Clin       Date:  2019-10-12

Review 8.  An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide.

Authors:  Martina A McAteer; Asim M Akhtar; Constantin von Zur Muhlen; Robin P Choudhury
Journal:  Atherosclerosis       Date:  2009-10-12       Impact factor: 5.162

9.  Conventional versus minimally invasive extracorporeal circulation in patients undergoing cardiac surgery: protocol for a randomised controlled trial (COMICS).

Authors: 
Journal:  Perfusion       Date:  2020-08-12       Impact factor: 1.972

10.  Sivelestat attenuates myocardial reperfusion injury during brief low flow postischemic infusion.

Authors:  Sverre E Aune; Steve T Yeh; Periannan Kuppusamy; M Lakshmi Kuppusamy; Mahmood Khan; Mark G Angelos
Journal:  Oxid Med Cell Longev       Date:  2013-05-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.